Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges

被引：24
|
作者：
Vitorino, Carla [1 ,2 ,3 ]
Silva, Soraia [1 ,2 ]
Bicker, Joana [1 ,2 ]
Falcao, Amilcar [1 ,2 ,4 ]
Fortuna, Ana [1 ,2 ,4 ]
机构：
[1] Univ Coimbra, Fac Pharm, Coimbra, Portugal
[2] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal
[3] Univ Coimbra, Coimbra Chem Ctr, Dept Chem, Coimbra, Portugal
[4] Univ Coimbra, Coimbra Inst Biomed Imaging & Translat Res, CIBIT ICNAS, Coimbra, Portugal
来源：
DRUG DISCOVERY TODAY | 2019年 / 24卷 / 09期
关键词：
DRUG-DELIVERY; INTRANASAL INSULIN; NEUROPEPTIDE-Y; DOUBLE-BLIND; ANXIETY; SYSTEM; NANOPARTICLES; ESKETAMINE; DISORDERS; COGNITION;
D O I：
10.1016/j.drudis.2019.06.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Why is nose-to-brain delivery considered to be a strategy that directly allows the access of antidepressants to the brain? In which circumstances can the intranasal pathway be applicable? Are there any requirements to follow? What triggers the antidepressant market? Which constraints are imposed during discovery programs? What opportunities can arise and what is their current status of development? Are they already translated into clinical practice? Which challenges are expected from recent development strategies? This review aims at providing a critical appraisal of nose-to-brain delivery of antidepressants, framed within a comprehensive analysis of drivers, restraints, opportunities and challenges.
引用
收藏
页码：1911 / 1923
页数：13
相关论文
共 50 条
  • [1] Nose-to-Brain Delivery
    Wang, Zian
    Xiong, Guojun
    Tsang, Wai Chun
    Schatzlein, Andreas G.
    Uchegbu, Ijeoma F.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 370 (03): : 593 - 601
  • [2] Nose-to-Brain Delivery
    Giunchedi, Paolo
    Gavini, Elisabetta
    Bonferoni, Maria Cristina
    PHARMACEUTICS, 2020, 12 (02)
  • [3] Nose-to-brain delivery of tacrine
    Jogani, Viral V.
    Shah, Pranav J.
    Mishra, Pushpa
    Mishra, Anil Kumar
    Misra, Ambikanandan R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (09) : 1199 - 1205
  • [4] Nose-to-brain delivery of biologics
    Schwarz, Bettina
    Merkel, Olivia M.
    THERAPEUTIC DELIVERY, 2019, 10 (04) : 207 - 210
  • [5] Nanoemulsions for "Nose-to-Brain" Drug Delivery
    Bonferoni, Maria Cristina
    Rossi, Silvia
    Sandri, Giuseppina
    Ferrari, Franca
    Gavini, Elisabetta
    Rassu, Giovanna
    Giunchedi, Paolo
    PHARMACEUTICS, 2019, 11 (02):
  • [6] Nose-to-brain peptide delivery - The potential of nanotechnology
    Samaridou, Eleni
    Alonso, Maria Jose
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (10) : 2888 - 2905
  • [7] SLN approach for nose-to-brain delivery of alprazolam
    Alok Pratap Singh
    Shailendra K. Saraf
    Shubhini A. Saraf
    Drug Delivery and Translational Research, 2012, 2 : 498 - 507
  • [8] SLN approach for nose-to-brain delivery of alprazolam
    Singh, Alok Pratap
    Saraf, Shailendra K.
    Saraf, Shubhini A.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2012, 2 (06) : 498 - 507
  • [9] Nanoparticles for direct nose-to-brain delivery of drugs
    Mistry, Alpesh
    Stolnik, Snjezana
    Illum, Lisbeth
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 379 (01) : 146 - 157
  • [10] Nose-to-brain drug delivery: Challenges and progress towards brain targeting in the treatment of neurological disorders
    Raghav, Meenakshi
    Gupta, Vaishnavi
    Awasthi, Rajendra
    Singh, Anurag
    Kulkarni, Giriraj
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 86
12345